Surabhi Mulchandani1, Elizabeth J Bhoj2, Minjie Luo1, Nina Powell-Hamilton3, Kim Jenny3, Karen W Gripp3, Miriam Elbracht4, Thomas Eggermann4, Claire L S Turner5, I Karen Temple6,7, Deborah J G Mackay7, Holly Dubbs2, David A Stevenson8, Leah Slattery8, Elaine H Zackai2, Nancy B Spinner1, Ian D Krantz2, Laura K Conlin1. 1. Division of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 2. Division of Clinical Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 3. Division of Medical Genetics, Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA. 4. Institute of Human Genetics, University Hospital, RWTH Aachen, Aachen, Germany. 5. Peninsula Clinical Genetics Service, Royal Devon and Exeter Hospital, Exeter, UK. 6. Wessex Clinical Genetics Service, University Hospital Southampton, Southampton, UK. 7. Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. 8. Division of Medical Genetics, Stanford University, Stanford, California, USA.
Abstract
PURPOSE: Maternal uniparental disomy of chromosome 20 (UPD(20)mat) has been reported in only four patients, three of whom also had mosaicism for complete or partial trisomy of chromosome 20. We sought to evaluate the clinical significance of isolated UPD(20)mat in eight individuals. METHODS: We evaluated phenotypic and genomic findings of a series of eight new patients with UPD(20)mat. RESULTS: All eight individuals with UPD(20)mat had intrauterine growth restriction, short stature, and prominent feeding difficulties with failure to thrive. As a common feature, they often required gastric tube feeds. Genomic data in most patients are indicative of UPD as a result of trisomy rescue after meiosis II nondisjunction. CONCLUSION: We describe the first natural history of the disorder and the results of therapeutic interventions, including the frequent requirement of direct gastric feedings only during the first few years of life, and propose that growth hormone supplementation is probably safe and effective for this condition. We suggest that UPD(20)mat can be regarded as a new imprinting disorder and its identification requires specialized molecular testing, which should be performed in patients with early-onset idiopathic isolated growth failure.Genet Med 18 4, 309-315.
PURPOSE: Maternal uniparental disomy of chromosome 20 (UPD(20)mat) has been reported in only four patients, three of whom also had mosaicism for complete or partial trisomy of chromosome 20. We sought to evaluate the clinical significance of isolated UPD(20)mat in eight individuals. METHODS: We evaluated phenotypic and genomic findings of a series of eight new patients with UPD(20)mat. RESULTS: All eight individuals with UPD(20)mat had intrauterine growth restriction, short stature, and prominent feeding difficulties with failure to thrive. As a common feature, they often required gastric tube feeds. Genomic data in most patients are indicative of UPD as a result of trisomy rescue after meiosis II nondisjunction. CONCLUSION: We describe the first natural history of the disorder and the results of therapeutic interventions, including the frequent requirement of direct gastric feedings only during the first few years of life, and propose that growth hormone supplementation is probably safe and effective for this condition. We suggest that UPD(20)mat can be regarded as a new imprinting disorder and its identification requires specialized molecular testing, which should be performed in patients with early-onset idiopathic isolated growth failure.Genet Med 18 4, 309-315.
Authors: I Chudoba; Y Franke; G Senger; G Sauerbrei; S Demuth; V Beensen; A Neumann; I Hansmann; U Claussen Journal: Eur J Hum Genet Date: 1999-07 Impact factor: 4.246
Authors: S Yu; O Gavrilova; H Chen; R Lee; J Liu; K Pacak; A F Parlow; M J Quon; M L Reitman; L S Weinstein Journal: J Clin Invest Date: 2000-03 Impact factor: 14.808
Authors: Emily Graves Allen; Sallie B Freeman; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Stephanie L Sherman Journal: Hum Genet Date: 2008-12-03 Impact factor: 4.132
Authors: Rebecca L Poole; Louise E Docherty; Abeer Al Sayegh; Almuth Caliebe; Claire Turner; Emma Baple; Emma Wakeling; Lucy Harrison; Anna Lehmann; I Karen Temple; Deborah J G Mackay Journal: Am J Med Genet A Date: 2013-08-02 Impact factor: 2.802
Authors: Charles P Venditti; Piper Hunt; Alan Donnenfeld; Elaine Zackai; Nancy B Spinner Journal: Am J Med Genet A Date: 2004-01-30 Impact factor: 2.802
Authors: Emma L Wakeling; Frédéric Brioude; Oluwakemi Lokulo-Sodipe; Susan M O'Connell; Jennifer Salem; Jet Bliek; Ana P M Canton; Krystyna H Chrzanowska; Justin H Davies; Renuka P Dias; Béatrice Dubern; Miriam Elbracht; Eloise Giabicani; Adda Grimberg; Karen Grønskov; Anita C S Hokken-Koelega; Alexander A Jorge; Masayo Kagami; Agnes Linglart; Mohamad Maghnie; Klaus Mohnike; David Monk; Gudrun E Moore; Philip G Murray; Tsutomu Ogata; Isabelle Oliver Petit; Silvia Russo; Edith Said; Meropi Toumba; Zeynep Tümer; Gerhard Binder; Thomas Eggermann; Madeleine D Harbison; I Karen Temple; Deborah J G Mackay; Irène Netchine Journal: Nat Rev Endocrinol Date: 2016-09-02 Impact factor: 43.330
Authors: Quixia Cui; Cagri Aksu; Birol Ay; Claire E Remillard; Antonius Plagge; Mina Gardezi; Margaret Dunlap; Louis C Gerstenfeld; Qing He; Murat Bastepe Journal: Front Genet Date: 2021-06-17 Impact factor: 4.599